Pharmafile Logo
- PMLiVE

Pharmaceutical Market Europe – September 2016

How confident are you in your country’s healthcare system? It’s the central issue for this month’s cover feature, which focuses on a global study of healthcare perceptions and offers up...

- PMLiVE

Pharmaceutical Market Europe – July/August 2016

Generating customer value, biosimilars, Brexit implications and immunotherapy directions

- PMLiVE

Pharmaceutical Market Europe – June 2016

Diversification, Brexit, rare diseases and the power of brand creativity

- PMLiVE

Pharmaceutical Market Europe – May 2016

The time for change is now, as our cover feature on medical affairs puts it, but there’s a transitional theme to much of this month’s PME

- PMLiVE

Pharmaceutical Market Europe – April 2016

Merck's Uta Kemmerich-Keil talks to PME about adding value, Amgen’s Sue Rees argues the case for pharmacovigilance and we assess access to health services in Europe.

- PMLiVE

Pharmaceutical Market Europe – March 2016

This month PME met Novo Nordisk’s senior vice president for marketing, medical affairs and stakeholder engagement Christian Kanstrup, heard from EphEMRA and looks at some new roles for social media.

- PMLiVE

Pharmaceutical Market Europe – February 2016

Transformation is, once again, in the pharma air this month, with a shakeup at Novartis as it revamps its business and looks to reinvigorate its underperforming eyecare division Alcon.

- PMLiVE

Pharmaceutical Market Europe – January 2016

Welcome to your first PME of 2016, which in company terms has already started with a bang and the news of Shire’s acquisition of Baxalta for $32bn - coincidentally the...

- PMLiVE

Pharmaceutical Market Europe – December 2015

Marketing innovation against a backdrop of restricted budgets

- PMLiVE

Pharmaceutical Market Europe – November 2015

In the November issue of PME we speak to Astellas about its first decade of operations and where it hopes to move over the next ten years.

- PMLiVE

Pharmaceutical Market Europe – October 2015

In the October issue of PME we look at how Bayer has been transforming its approach to technology and working to build digital into its DNA.

- PMLiVE

Pharmaceutical Market Europe – September 2015

In September’s PME we look at the local role for global market access teams, and pose the six big questions that will shape your access strategy.